LTRN icon

Lantern Pharma

33 hedge funds and large institutions have $13.1M invested in Lantern Pharma in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+8
Holders Change %
+32%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
12
Reduced
3
Closed
5
Calls
$2K
Puts
$122K
Net Calls
-$120K
Net Calls Change
-$120K
Name Holding Trade Value Shares
Change
Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$42K +$42K +5,250 New
SWM
27
Spire Wealth Management
Virginia
$32K +$23.7K +3,000 +286%
Bank Julius Baer & Co
28
Bank Julius Baer & Co
Switzerland
$20K +$8K +1,000 +67%
TRCT
29
Tower Research Capital (TRC)
New York
$13K +$8.73K +1,082 +204%
Wells Fargo
30
Wells Fargo
California
$9K +$2.04K +279 +29%
SPIA
31
Steward Partners Investment Advisory
New York
$2K
CA
32
Corriente Advisors
Texas
-$7M -625,873 Closed
RJA
33
Raymond James & Associates
Florida
-$289K -25,879 Closed
US Bancorp
34
US Bancorp
Minnesota
-$22K -2,000 Closed
AF
35
Advisornet Financial
Minnesota
-$6K -500 Closed